PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Anthem BCBSCommercial · Prior Auth · Pharmacy · VA · Oncology, Hematology, PharmacyHigh impact

[Virginia] Specialty pharmacy updates — July 2026

Act
by Jul 1, 2026
Effective date
Jul 1, 2026
Identified
Jun 26, 2026

Summary

Anthem Blue Cross and Blue Shield (Virginia) is implementing new prior authorization, quantity limit, and step therapy requirements for three specialty pharmacy medications effective July 1, 2026, with additional clinical criteria revisions effective October 1, 2026. Patients currently receiving these medications without prior authorization will require approval going forward, and certain previously covered services may now be deemed not medically necessary under revised clinical criteria.

Get alerts when payers change rules like this one

We check Anthem BCBS and other payers every day and email you when a change matches your specialty and state.

Get Anthem BCBS alertsPolicy Monitoring is free. No card required.

What to do

by Jul 1, 2026 · 9 steps
01Billing and authorization teams must implement prior authorization requirements for specialty pharmacy claims using HCPCS codes C9399 and J3590 for the following medications: Avlayah (tividenofusp alfa-eknm), Filkri (filgrastim-laha), and Ponlimsi (denosumab-adet).
02Update billing software to flag these codes for mandatory prior authorization before claim submission.
03For Filkri and Ponlimsi, configure system to treat as non-preferred with step therapy requirements.
04Apply quantity limits for Avlayah and Ponlimsi.
05For oncology uses of Filkri and Ponlimsi, route authorization requests to Carelon Medical Benefits Management.
06Providers must document medical necessity with all prior authorization submissions.
07Claims submitted without prior authorization will be denied.
08Additionally, before October 1, 2026, review and update coverage criteria in billing system for the 15 revised Clinical Criteria drugs (including Keytruda, Bevacizumab, Imfinzi, Trodelvy, and others) as previously covered services may now be denied as not medically necessary.
09Train billing staff on new workflows and access Availity for payer communication.

Codes mentioned

C9399J3590

Original notice

[Virginia] Specialty pharmacy updates — July 2026
providernews.anthem.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account